Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan: revance.com (RVNC)

Revance Therapeutics Inc - logo grafis emiten RVNC

The expansion of Daxxify and new therapeutic targets are driving the growth of Revance Therapeutics (RVNC). The quarterly EPS growth rate demonstrates the dynamics of earnings per share, while 77.10 reflects the latest level of this metric. Revenues are based on demand from dermatologists and aesthetic clinics. Operational stability is supported by the US domestic market and a neutral geopolitical backdrop for the industry.

Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan revance.com (RVNC): kanggo periode 04.07.2022 - 16.02.2025

Rincian metrik keuangan lan pasar Revance Therapeutics (RVNC)

- rega saham lan prakiraan rega para ahli:
- indikator kapitalisasi bursa perusahaan:
Analisis wiwitan perusahaan:Revance Therapeutics
Produk dadi Revance Therapeutics Inc

Revance Therapeutics (RVNC) expansion into the neuromodulator segment via the drug Daxxify is reflected in the quarterly EPS growth rate, which serves as an indicator of business scaling efficiency. This metric is based on a probabilistic recalculation of net income per share growth rates, where prolonged stagnation of the line signals the accumulation of a systemic imbalance, foreshadowing either a sharp price impulse or a deep capital correction.

Pesaing wigati

KRYS: Wutah bathi EPS kuartalan|APGE - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Arcutis Biotherapeutics, Inc.|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan VCEL (Vericel)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Oruka Pharma (ORKA)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan Sanara MedTech|Wutah bathi EPS kuartalan DBVT (DBV Technologies SA)|Solesence Inc (SLSN) - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|DERM: Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan FBRX (Forte Biosciences)|Empro Group (EMPG) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi resik saben saham sajroning taun lumaku Sol-Gel Technologies Ltd. SLGL|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan AXIL|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan Medicus Pharma Ltd. (MDCX)|Wutah bathi EPS kuartalan VRCA|Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan HOTH|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan biofrontera-us.com BFRI|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan VYNE|SNOA - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan QNRX (quoinpharma.com)|Azitra (AZTR) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|DRMA: Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|ELAB (Elevai Labs) - Wutah bathi EPS kuartalan